The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation.

Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk

High affinity binding of amyloid β-peptide to calmodulin: Structural and functional implications.

Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer’s Disease Related Pathology and Cognitive Decline

The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer’s Disease Cohorts

ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?

Apolipoprotein E: Essential Catalyst of the Alzheimer Amyloid Cascade

Peptides for Therapy and Diagnosis of Alzheimer’s Disease

Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging

Regulation of IL-1β-Induced Cyclooxygenase-2 Expression by Interactions of Aβ Peptide, Apolipoprotein E and Nitric Oxide in Human Neuroglioma

Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.

The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation.

Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk

High affinity binding of amyloid β-peptide to calmodulin: Structural and functional implications.

Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer’s Disease Related Pathology and Cognitive Decline

The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer’s Disease Cohorts

ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?

Apolipoprotein E: Essential Catalyst of the Alzheimer Amyloid Cascade

Peptides for Therapy and Diagnosis of Alzheimer’s Disease

Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging

Regulation of IL-1β-Induced Cyclooxygenase-2 Expression by Interactions of Aβ Peptide, Apolipoprotein E and Nitric Oxide in Human Neuroglioma

Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.

The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation.

Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk

High affinity binding of amyloid β-peptide to calmodulin: Structural and functional implications.

Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer’s Disease Related Pathology and Cognitive Decline

The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer’s Disease Cohorts

ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?

Apolipoprotein E: Essential Catalyst of the Alzheimer Amyloid Cascade

Peptides for Therapy and Diagnosis of Alzheimer’s Disease

Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging

Regulation of IL-1β-Induced Cyclooxygenase-2 Expression by Interactions of Aβ Peptide, Apolipoprotein E and Nitric Oxide in Human Neuroglioma

Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.